Few hospital-acquired infections are as antibiotic-resistant as Pseudomonas aeruginosa. This opportunistic germ has earned a reputation for beating nearly every drug in the doctor’s arsenal. It ...

Colorectal cancer is a leading cause of cancer-related deaths worldwide. For patients with metastatic disease, treatment options are limited and the prognosis is often poor. Regorafenib, a ...

Scientists at the Ineos Oxford Institute (IOI) have found a new potential combination therapy to combat antimicrobial resistance (AMR) by targeting two key bacterial enzymes involved in resistance.

A research team has investigated a new combination therapy against cancer. This therapy employs systemic administration of the tissue hormone interferon-I combined with local application of Imiquimod.

A new clinical trial suggests that pairing bispecific antibodies and antibody-drug conjugates with CAR T-cell therapy may sharply boost one-year progression-free survival for people with aggressive ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Combining two cancer drugs has been found to prolong the lifespan of ...

A study has revealed why some patients don't respond to immune checkpoint blockade (ICB) therapy for solid cancer tumors and identifies a new combination treatment. Publishing in Nature Immunology, ...